Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Seres Therapeutics Ltd News

    0,7268 € 0,00% +0,00 €
    11:43:49 Uhr Gettex aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A14VXX
    ISIN: US81750R1023
    US-Symbol: MCRB
    Typ: Aktie

    Seres Therapeutics Ltd News

    09.01.24 - PR Newswire
    Thinking about buying stock in Grifols, Esperion Therapeutics, Rithm Capital, Applied Optoelectronics, or Seres Therapeutics?
    Thinking about buying stock in Grifols, Esperion Therapeutics, Rithm Capital, Applied Optoelectronics, or Seres Therapeutics? PR Newswire
    27.11.23 - PR Newswire
    Flagship Pioneering Marks Official Opening of UK Hub with Event Convening Life Science Leaders
    Flagship Pioneering Marks Official Opening of UK Hub with Event Convening Life Science Leaders PR Newswire
    21.11.23 - PR Newswire
    Flagship Pioneering Unveils Quotient Therapeutics to Create Transformative Medicines Informed by a New Frontier of Genetics
    Flagship Pioneering Unveils Quotient Therapeutics to Create Transformative Medicines Informed by a New Frontier of Genetics PR Newswire
    01.11.23 - PR Newswire
    Flagship Pioneering Launches Pioneering Intelligence
    Flagship Pioneering Launches Pioneering Intelligence PR Newswire
    11.09.23 - PR Newswire
    Flagship Pioneering Announces Appointment of Amanda Kay as Chief Business Development Officer
    Flagship Pioneering Announces Appointment of Amanda Kay as Chief Business Development Officer PR Newswire
    29.08.23 - PR Newswire
    Invaio achieves first registration for citrus greening solution featuring Trecise™ technology
    Invaio achieves first registration for citrus greening solution featuring Trecise™ technology PR Newswire
    16.05.23 - PR Newswire
    Flagship Pioneering Launches Metaphore Biotechnologies to Unlock the Therapeutic Potential of Biomimicry
    Flagship Pioneering Launches Metaphore Biotechnologies to Unlock the Therapeutic Potential of Biomimicry PR Newswire
    23.09.22 - PR Newswire
    Thinking about buying stock in Rubius Therapeutics, NextPlat, Seres Therapeutics, Cassava Sciences, or Alaunos Therapeutics?
    Thinking about buying stock in Rubius Therapeutics, NextPlat, Seres Therapeutics, Cassava Sciences, or Alaunos Therapeutics? PR Newswire
    08.07.22 - PR Newswire
    Thinking about buying stock in Aprea Therapeutics, Dermata Therapeutics, Seres Therapeutics, Avadel Pharmaceuticals, or Clovis Oncology?
    Thinking about buying stock in Aprea Therapeutics, Dermata Therapeutics, Seres Therapeutics, Avadel Pharmaceuticals, or Clovis Oncology? PR Newswire
    28.02.22 - PR Newswire
    Alltrna Appoints Rare Disease Clinical Research Expert, Dr. Anne Pariser, as Vice President, Medical and Regulatory Affairs
    Alltrna Appoints Rare Disease Clinical Research Expert, Dr. Anne Pariser, as Vice President, Medical and Regulatory Affairs PR Newswire
    15.02.22 - PR Newswire
    INVAIO SCIENCES STRENGTHENS ITS BOARD OF DIRECTORS WITH THE APPOINTMENT OF HUGH GRANT
    INVAIO SCIENCES STRENGTHENS ITS BOARD OF DIRECTORS WITH THE APPOINTMENT OF HUGH GRANT PR Newswire
    22.07.21 - PR Newswire
    Thinking about buying stock in PainReform, Norwegian Cruise Line, Seres Therapeutics, CSX Corp, or Neptune Wellness Solutions?
    Thinking about buying stock in PainReform, Norwegian Cruise Line, Seres Therapeutics, CSX Corp, or Neptune Wellness Solutions? PR Newswire
    22.07.21 - PR Newswire
    Thinking about buying stock in Hyzon Motors, Costamare, RealReal, Tri Pointe Homes, or Seres Therapeutics?
    Thinking about buying stock in Hyzon Motors, Costamare, RealReal, Tri Pointe Homes, or Seres Therapeutics? PR Newswire
    14.06.21 - PR Newswire
    Dr. Stephen Hahn, 24th US FDA Commissioner and Former Chief Medical Executive at MD Anderson, joins Flagship Pioneering as Chief Medical Officer of Flagship's Preemptive Medicine and Health Security Initiative
    Dr. Stephen Hahn, 24th US FDA Commissioner and Former Chief Medical Executive at MD Anderson, joins Flagship Pioneering as Chief Medical Officer of Flagship's Preemptive ...
    25.05.21 - PR Newswire
    Invaio Sciences Raises $88.9 Million to Accelerate the Transition to Biological Agriculture
    Invaio Sciences Raises $88.9 Million to Accelerate the Transition to Biological Agriculture PR Newswire
    19.05.21 - PR Newswire
    Invaio Sciences Announces Key Agreement with Fundecitrus in Brazil to Combat Against Citrus Greening
    Invaio Sciences Announces Key Agreement with Fundecitrus in Brazil to Combat Against Citrus Greening PR Newswire
    30.03.21 - PR Newswire
    Invaio Sciences Strengthens Leadership Team with Appointment of Peleg Chevion as President and Chief Commercial Officer
    Invaio Sciences Strengthens Leadership Team with Appointment of Peleg Chevion as President and Chief Commercial Officer PR Newswire
    25.02.21 - PR Newswire
    Cellarity Raises $123 Million in Series B Funding to Pioneer a New Approach to Drug Discovery, Treating Disease at the Level of the Cell as Opposed to a Single Molecular Target
    Cellarity Raises $123 Million in Series B Funding to Pioneer a New Approach to Drug Discovery, Treating Disease at the Level of the Cell as Opposed to a Single Molecular Target ...
    18.08.20 - PR Newswire
    Thinking about trading options or stock in Seres Therapeutics, Principia Biopharma, United Airlines Holdings, Ford Motor, or MGM Resorts?
    Thinking about trading options or stock in Seres Therapeutics, Principia Biopharma, United Airlines Holdings, Ford Motor, or MGM Resorts? PR Newswire
    10.08.20 - PR Newswire
    Thinking about buying stock in Trevena Inc, Seres Therapeutics, CleanSpark Inc, Lipocine Inc, or Tilray Inc?
    Thinking about buying stock in Trevena Inc, Seres Therapeutics, CleanSpark Inc, Lipocine Inc, or Tilray Inc? PR Newswire

    Newssuche

    Videos

    08:40 Uhr +19,34%
    Technical Trading: Gold Long freitags
    Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »